CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Clinical trials for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL explained in plain language.
Never miss a new study
Get alerted when new CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL trials appear
Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common gout drug slow heart disease in people with a gene variant?
Disease control Not yet recruitingThis study tests whether colchicine, a drug used for gout, can slow the buildup of plaque in heart arteries. It includes 120 adults aged 40-85 who recently had a heart attack and have a specific gene variant (TET2-CHIP). Researchers will measure plaque changes using CT scans over…
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Massive study to uncover hidden links between immune Flare-Ups and blood cancers
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults who have immune system problems (like inflammation or autoimmune disease) to see how often they also develop blood disorders, including a rare condition called VEXAS syndrome. Researchers will track new cases over time to better understand the …
Matched conditions: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC